Skinvisible, Inc. (SKVI)
OTCMKTS · Delayed Price · Currency is USD
0.1700
-0.0320 (-15.84%)
At close: May 7, 2026
Skinvisible Revenue
In the year 2025, Skinvisible had annual revenue of $20.00K. Skinvisible had revenue of $5.00K in the quarter ending December 31, 2025.
Revenue
20.00K
Revenue Growth
n/a
P/S Ratio
45.93
Revenue / Employee
10.00K
Employees
2
Market Cap
918.65K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 20.00K | - | - |
| Dec 31, 2024 | 20.00K | - | - |
| Dec 31, 2023 | 20.00K | -259.30K | -92.84% |
| Dec 31, 2022 | 279.30K | -384.13K | -57.90% |
| Dec 31, 2021 | 663.43K | 387.87K | 140.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| The Stephan Co. | 15.66M |
| CCA Industries | 7.74M |
| PURE Bioscience | 2.41M |
| Longevity Health Holdings | 1.91M |
| Sentient Brands Holdings | 701.46K |
| Winning Brands | 407.23K |
| Peregrine Industries | 20.88K |
| Bemax | 6.38K |
Skinvisible News
- 8 months ago - Ovation Science and Skinvisible Pharmaceuticals Enhance Their Strategic Partnership in the Obesity Market with Innovative Cannabinoid Delivery Technology with New Developments and Patent Protection - Accesswire
- 1 year ago - Skinvisible Reports Licensee Success in Netherton Syndrome Clinical Studies - Accesswire
- 1 year ago - Skinvisible announces article on transdermal obesity formulation development - TheFly
- 1 year ago - Skinvisible Announces Article Highlighting Its Proprietary Transdermal Obesity Formulation Development - Accesswire
- 1 year ago - Promising Data on Transdermal Obesity Formulations Announced by Skinvisible - Accesswire
- 1 year ago - Skinvisible Inc unveils data on transdermal obesity formulations - TheFly
- 2 years ago - Skinvisible Inc expands obesity patent application for transdermal delivery - TheFly
- 2 years ago - Skinvisible Expands Obesity Patent Application for Transdermal Delivery - Accesswire